World's Best Scientists 2026 revealed!
Award Badge
Medicine
Spain
2023

D-Index & Metrics

Medicine

D-Index
145
Citations
121588
World Ranking
1356
National Ranking
14

Research.com Recognitions

  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Josep Tabernero is affiliated with the Vall d´Hebron Institute of Oncology in Spain. Their research focuses primarily on oncology, with significant contributions spanning colorectal cancer treatments and studies, gastric cancer management and outcomes, cancer genomics and diagnostics, cancer immunotherapy and biomarkers, lung cancer treatments and mutations, genetic factors in colorectal cancer, and cancer treatment and pharmacology.

They have authored numerous publications across several key venues in oncology and cancer research. These venues include:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • ESMO Open
  • Clinical Cancer Research
  • Future Oncology

The following represent some of their recent papers, detailing titles, years, and publication outlets:

  • Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study, 2021, Journal of Clinical Oncology
  • Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2020, Annals of Oncology
  • Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer, 2020, JAMA Oncology
  • The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer, 2021, Nature
  • Clinical management of metastatic colorectal cancer in the era of precision medicine, 2022, CA A Cancer Journal for Clinicians

Frequent co-authors collaborating with Josep Tabernero include:

  • Eric Van Cutsem
  • Elena Élez
  • Takayuki Yoshino
  • Elena Garralda
  • N. Saoudi Gonzalez

Their work spans a broad scope of main and subfields of study within medicine, with a particular focus on:

  • Medicine
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research
  • Molecular Biology
  • Pathology and Forensic Medicine

Best Publications

  • Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

    Daniel D. Von Hoff;Thomas Ervin;Francis P. Arena;E. Gabriela Chiorean

  • The consensus molecular subtypes of colorectal cancer

    Justin Guinney;Rodrigo Dienstmann;Rodrigo Dienstmann;Xingwu Wang;Xingwu Wang;Aurélien De Reyniès

  • Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

    Thierry Andre;Corrado Boni;Lamia Mounedji-Boudiaf;Matilde Navarro

  • The landscape of somatic copy-number alteration across human cancers

    Rameen Beroukhim;Craig H. Mermel;Craig H. Mermel;Dale Porter;Guo Wei

  • ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    E. Van Cutsem;A. Cervantes;R. Adam;A. Sobrero

  • Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

    Axel Grothey;Eric Van Cutsem;Alberto Sobrero;Salvatore Siena

  • Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

    Thierry Andre;Corrado Boni;Matilde Navarro;Josep Tabernero

  • Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

    Charles S Fuchs;Jiri Tomasek;Cho Jae Yong;Filip Dumitru

  • Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer

    Jean Yves Douillard;Kelly S. Oliner;Salvatore Siena;Josep Tabernero

  • Genomic analysis identifies association of Fusobacterium with colorectal carcinoma

    Aleksandar D. Kostic;Dirk Gevers;Chandra Sekhar Pedamallu;Chandra Sekhar Pedamallu;Monia Michaud

  • Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    Wendy De Roock;Bart Claes;David Bernasconi;Jef De Schutter

  • ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    H J Schmoll;E Van Cutsem;A Stein;V Valentini

  • Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

    David M. Hyman;Igor Puzanov;Vivek Subbiah;Jason E. Faris

  • Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study

    Jean Yves Douillard;Salvatore Siena;James Cassidy;Josep Tabernero

  • Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer

    Susan Bullman;Susan Bullman;Chandra S. Pedamallu;Chandra S. Pedamallu;Ewa Sicinska;Thomas E. Clancy

  • Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

    Robert J Mayer;Eric Van Cutsem;Alfredo Falcone;Takayuki Yoshino

  • Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

    Scott Kopetz;Axel Grothey;Rona Yaeger;Eric Van Cutsem

  • Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

    Eric Van Cutsem;Josep Tabernero;Radek Lakomy;Hans Prenen

  • Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): A randomised, double-blind, multicentre, phase 3 study

    Josep Tabernero;Takayuki Yoshino;Allen Lee Cohn;Radka Obermannova

  • Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

    Priscilla K. Brastianos;Scott L. Carter;Scott L. Carter;Sandro Santagata;Sandro Santagata;Daniel P. Cahill

Frequent Co-Authors

José Baselga
José Baselga Memorial Sloan Kettering Cancer Center
Andrés Cervantes
Andrés Cervantes University of Valencia
Takayuki Yoshino
Takayuki Yoshino University of Tsukuba
Salvatore Siena
Salvatore Siena University of Milan
Fortunato Ciardiello
Fortunato Ciardiello University of Campania "Luigi Vanvitelli"
Paolo Nuciforo
Paolo Nuciforo Vall d´Hebron Institute of Oncology
David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust
Axel Grothey
Axel Grothey University of Tennessee at Knoxville

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open diverse career pathways for students interested in health and medicine. For those passionate about wellness, an online BS in nutrition offers flexibility and foundational knowledge in dietetics, community health, and food science.

Aspiring leaders may consider cahme accredited online healthcare administration programs for developing management skills crucial for hospital and health system operations. These accredited degrees ensure quality online instruction and are valued by employers.

Registered nurses seeking advancement can benefit from online rn to bsn no clinicals programs, which allow licensed nurses to expand their qualifications without on-site clinical requirements—ideal for working professionals.

Advanced nursing roles are within reach through accelerated dnp programs, which offer a fast-track route to a Doctor of Nursing Practice. These streamlined options help nurses make a significant impact in healthcare leadership, policy, and research.

Best Scientists Citing Josep Tabernero

Trending Scientists

Recently Published Articles